The OMERACT core domain set for outcome measures for clinical trials in polymyalgia rheumatica
SL Mackie, H Twohig, LM Neill, E Harrison… - The Journal of …, 2017 - jrheum.org
Objective. To inform development of a core domain set for outcome measures for clinical trials
in polymyalgia rheumatica (PMR), we conducted patient consultations, a systematic review…
in polymyalgia rheumatica (PMR), we conducted patient consultations, a systematic review…
Development of a provisional core domain set for polymyalgia rheumatica: report from the OMERACT 12 Polymyalgia Rheumatica Working Group
…, CT Pease, R Hughes, CL Hill, LM Neill… - The Journal of …, 2016 - jrheum.org
Objective. The Outcome Measures in Rheumatology (OMERACT) polymyalgia rheumatica (PMR)
working group aims to develop a core set of outcome measures to be used in clinical …
working group aims to develop a core set of outcome measures to be used in clinical …
Test-retest reliability of pain VAS/NRS, stiffness VAS/NRS, HAQ-DI and mHAQ in polymyalgia rheumatica: An OMERACT study
…, S Muller, L Maxwell, SL Mackie, LM Neill… - Seminars in Arthritis and …, 2023 - Elsevier
… Mackie e f , Lorna M Neill g , Claire E. Owen a b , OMERACT PMR Working Group … Lorna
M. Neill has received honoraria from AbbVie and is a trustee of PMR-GCA Scotland Charity. …
M. Neill has received honoraria from AbbVie and is a trustee of PMR-GCA Scotland Charity. …
Toward a core outcome measurement set for polymyalgia rheumatica: Report from the OMERACT 2018 special interest group
…, M Yates, H Twohig, S Muller, LM Neill… - The Journal of …, 2019 - jrheum.org
Objective. To report the progress of the Outcome Measures in Rheumatology (OMERACT)
Polymyalgia Rheumatica (PMR) Working Group in selecting candidate instruments for a core …
Polymyalgia Rheumatica (PMR) Working Group in selecting candidate instruments for a core …
[PDF][PDF] ¿ MI CASA ES SU CASA? SPANISH-SPEAKING HOME MORTGAGE BORROWERS NEED TO UNDERSTAND THEIR LOANS
LM Neill - Consumer Finance Law Quarterly Report, 2006 - files.klgates.com
In an increasingly competitive mortgage market, smart lenders are aggressively reaching
out to underserved markets. Among the most prominent of these markets is the growing …
out to underserved markets. Among the most prominent of these markets is the growing …
Development of a Provisional Core Domain Set for Polymyalgia Rheumatica: Report from the OMERACT
LM Neill, S Halls, LS Simon, CD Mallen… - The Journal of …, 2016 - jrheum.org
Objective. The Outcome Measures in Rheumatology (OMERACT) polymyalgia rheumatica (PMR)
working group aims to develop a core set of outcome measures to be used in clinical …
working group aims to develop a core set of outcome measures to be used in clinical …
[PDF][PDF] The OMERΑCT Core Domain Set for Outcome Measures for Clinical Trials in Polymyalgia Rheumatica
SL Mackie, H Twohig, LM Neill, E Harrison, B Shea… - 2017 - core.ac.uk
… Mackie1, Helen Twohig2, Lorna M Neill3, Eileen Harrison4, Beverley Shea5, Rachel J Black6,
Tanaz A Kermani7, Peter A Merkel8, Christian Mallen9, Frank Buttgereit10, Chetan Mukhtyar11 …
Tanaz A Kermani7, Peter A Merkel8, Christian Mallen9, Frank Buttgereit10, Chetan Mukhtyar11 …
The quality of fresh‐frozen plasma produced from whole blood stored at 4° C overnight
R Cardigan, AS Lawrie, IJ Mackie, LM Williamson - Transfusion, 2005 - Wiley Online Library
BACKGROUND: The aim of this study was to assess whether the quality of FFP produced from
whole blood stored at 4C overnight is adequate for its intended purpose. STUDY DESIGN …
whole blood stored at 4C overnight is adequate for its intended purpose. STUDY DESIGN …
Effective bridging therapy can improve CD19 CAR-T outcomes while maintaining safety in patients with large B-cell lymphoma
…, M Marzolini, W Townsend, M O'Reilly… - Blood …, 2023 - ashpublications.org
The impact of bridging therapy (BT) on CD19-directed chimeric antigen receptor T-cell (CD19CAR-T)
outcomes in large B-cell lymphoma (LBCL) is poorly characterized. Current …
outcomes in large B-cell lymphoma (LBCL) is poorly characterized. Current …
[HTML][HTML] Clinical characteristics and treatment outcomes in a cohort of patients with pyogenic and amoebic liver abscess
L Neill, F Edwards, SM Collin, D Harrington… - BMC infectious …, 2019 - Springer
Background We describe the clinical features of a cohort of patients with liver abscesses
and investigate relationships between clinical, radiological and microbiological findings and …
and investigate relationships between clinical, radiological and microbiological findings and …